109 related articles for article (PubMed ID: 7502270)
1. Inhibition of red blood cell-induced platelet aggregation in whole blood by a nonionic surfactant, poloxamer 188 (RheothRx injection).
Armstrong JK; Meiselman HJ; Fisher TC
Thromb Res; 1995 Sep; 79(5-6):437-50. PubMed ID: 7502270
[TBL] [Abstract][Full Text] [Related]
2. The non-ionic surfactant Poloxamer 188 (RheothRx) increases plasma and whole blood viscosity.
Lechmann T; Reinhart WH
Clin Hemorheol Microcirc; 1998 Apr; 18(1):31-6. PubMed ID: 9653583
[TBL] [Abstract][Full Text] [Related]
3. The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction.
Toth K; Bogar L; Juricskay I; Keltai M; Yusuf S; Haywood LJ; Meiselman HJ
Clin Hemorheol Microcirc; 1997; 17(2):117-25. PubMed ID: 9255435
[TBL] [Abstract][Full Text] [Related]
4. Effects of the co-polymer surfactant, Pluronic F-68, on platelet aggregation in human whole blood.
Edwards CM; Heptinstall S; Lowe KC
Artif Cells Blood Substit Immobil Biotechnol; 1997 Sep; 25(5):493-9. PubMed ID: 9285052
[TBL] [Abstract][Full Text] [Related]
5. Modulation of red blood cell aggregation and blood viscosity by the covalent attachment of Pluronic copolymers.
Armstrong JK; Meiselman HJ; Wenby RB; Fisher TC
Biorheology; 2001; 38(2-3):239-47. PubMed ID: 11381178
[TBL] [Abstract][Full Text] [Related]
6. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE
Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of polymer-induced red blood cell aggregation by poloxamer 188.
Toth K; Wenby RB; Meiselman HJ
Biorheology; 2000; 37(4):301-12. PubMed ID: 11145076
[TBL] [Abstract][Full Text] [Related]
8. Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms.
Reimers RC; Sutera SP; Joist JH
Blood; 1984 Dec; 64(6):1200-6. PubMed ID: 6498335
[TBL] [Abstract][Full Text] [Related]
9. Effects of Poloxamer 188 on fibrin network structure, whole blood clot premeability and fibrinolysis.
van Gelder JM; Nair CH; Dhall DP
Thromb Res; 1993 Sep; 71(5):361-76. PubMed ID: 8236163
[TBL] [Abstract][Full Text] [Related]
10. RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: a pilot study.
Adams-Graves P; Kedar A; Koshy M; Steinberg M; Veith R; Ward D; Crawford R; Edwards S; Bustrack J; Emanuele M
Blood; 1997 Sep; 90(5):2041-6. PubMed ID: 9292541
[TBL] [Abstract][Full Text] [Related]
11. Effects of poloxamer 188 on the assembly, structure and dissolution of fibrin clots.
Carr ME; Powers PL; Jones MR
Thromb Haemost; 1991 Nov; 66(5):565-8. PubMed ID: 1803621
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes.
De La Cruz JP; Páez MV; Carmona JA; De La Cuesta FS
Br J Pharmacol; 1999 Dec; 128(7):1538-44. PubMed ID: 10602334
[TBL] [Abstract][Full Text] [Related]
13. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
14. Effects of RheothRx on mortality, morbidity, left ventricular function, and infarct size in patients with acute myocardial infarction. Collaborative Organization for RheothRx Evaluation (CORE).
Circulation; 1997 Jul; 96(1):192-201. PubMed ID: 9236434
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
16. Effects of pluronic F-68 (poloxamer 188) on platelet aggregation in human whole blood.
Edwards CM; May JA; Heptinstall S; Lowe KC
Thromb Res; 1996 Feb; 81(4):511-2. PubMed ID: 8907302
[No Abstract] [Full Text] [Related]
17. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial.
Schaer GL; Spaccavento LJ; Browne KF; Krueger KA; Krichbaum D; Phelan JM; Fletcher WO; Grines CL; Edwards S; Jolly MK; Gibbons RJ
Circulation; 1996 Aug; 94(3):298-307. PubMed ID: 8759069
[TBL] [Abstract][Full Text] [Related]
19. The ability of poloxamers to inhibit platelet aggregation depends on their physicochemical properties.
Ahmed F; Alexandridis P; Shankaran H; Neelamegham S
Thromb Haemost; 2001 Dec; 86(6):1532-9. PubMed ID: 11776324
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
Megson IL; Sogo N; Mazzei FA; Butler AR; Walton JC; Webb DJ
Br J Pharmacol; 2000 Dec; 131(7):1391-8. PubMed ID: 11090112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
